Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...
A study of U.S. veterans found that their episodic visual memory, motor learning, and sustained visual attention improved ...